LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/16/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
ST13
US500000079410002Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of the words "ID SOLUTIONS" in navy blue color with the dot on the letter "I" of "ID" in turquoise blue color, located above the word "ONCOLOGY" in turquoise blue color. The group of words "ID SOLUTIONS ONCOLOGY" is located to the right of a turquoise blue and navy blue double helix.
Holders
Representatives
J. Scott Gerien Dickenson, Peatman & Fogarty
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical preparations, namely, precursors intended for in vitro genetic engineering; diagnostic reagents for in vitro use for biochemistry, clinical chemistry and microbiology; chemical preparations for scientific purposes intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for nonmedical purposes; reagents for nucleic acid amplification other than for medical or veterinary use
Class 5
Diagnostic test kits comprised of medical diagnostic agents, preparations and substances for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects for medical purposes; chemical preparations intended for use in DNA analysis for medical use; reagents for use in medical genetic testing; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use
Class 9
Laboratory apparatus for detecting genetic sequences; quantitative polymerase chain reaction (PCR) instrument for scientific use, namely, thermal cycler; laboratory apparatus and automatic machines for purifying nucleic acids, not for medical purposes
Class 10
DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use; medical apparatus and automatic machines for purifying nucleic acids for medical use
Class 42
Research with respect to DNA sequencing technology; research in the field of DNA analysis technology; scientific research in the field of genetics and genetic engineering; structural and functional analysis of genomes; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of health; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of biology; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of in vitro diagnostics; design, development and maintenance of software in the field of health; design, development and maintenance of software in the field of biology; design, development and maintenance of software in the field of in vitro diagnostics.
History of USPTO decisions and trademark events.
28 publications found
LIMITATION OF GOODS RECEIVED FROM IB
07/16/2026
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2026
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/20/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/20/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
REGISTERED-PRINCIPAL REGISTER
01/20/2026
NOTIFICATION PROCESSED BY IB
12/11/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2025
PUBLISHED FOR OPPOSITION
12/02/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2025
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2025
REFUSAL PROCESSED BY IB
06/07/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/22/2025
REFUSAL PROCESSED BY MPU
05/22/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/27/2025
NON-FINAL ACTION WRITTEN
03/26/2025
ASSIGNED TO EXAMINER
03/06/2025
APPLICATION FILING RECEIPT MAILED
12/05/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2024
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/04/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2024
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.